Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Clinical Oncology|July 1, 2014
Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)Francis A S Lee, Benny Chung-Ying Zee, Foon Yiu Cheung, et al.Cancer Chemotherapy and Pharmacology|May 19, 2009
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignanciesChia-Chi Lin, Muralidhar Beeram, Eric K Rowinsky, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II studyAaron D Schimmer, Wolfgang Herr, Mathias Hänel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancerFernand Labrie, Pierre Champagne, Claude Labrie, et al.The Oncologist|December 4, 2020
Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, ExperienceCatherine Jolivet, Rami Nassabein, Denis Soulières, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemiaAaron D Schimmer, Elihu H Estey, Gautam Borthakur, et al.JCO Precision Oncology|February 9, 2022
Reflex Testing for Germline <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i>, and <i>ATM</i> Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research RegistriesAlyssa L Smith, Cavin Wong, Adeline Cuggia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as BiomarkersNeal Ready, Matthew D Hellmann, Mark M Awad, et al.Pageof 2